[18 July 2012]
Products Affected - Description
Surgilube, Savage Laboratories
Reason for the Shortage
- Savage Laboratories had Surgilube on shortage due to increased demand for the product.
- Triad recalled all surgical lubricating jelly in December, 2010 due to sterility issues. Triad has suspended all manufacturing operations indefinitely.
Available Products
Surgilube, Savage Laboratories
3 gram foilpac, 144 count (NDC 00281-0205-43)
5 gram foilpac, 144 count (NDC 00281-0205-45)
5 gram tube, 144 count (NDC 00281-0205-55)
2 ounce tube, 12 count (NDC 00281-0205-02)
2 ounce flipcap tube, 12 count (NDC 00281-0205-12)
41/4 ounce tube, 12 count (NDC 00281-0205-36)
41/4 ounce flipcap tube, 12 count (NDC 00281-0205-37)
Estimated Resupply Dates
Savage Laboratories has all presentations available.
Related Shortages
Updated
July 18, 2012; May 22, 2012; April 5, 2012; March 9, 2012; January 31, 2012; November 30, 2011; August 23, 2011, University of Utah, Drug Information Service. Copyright 2012, Drug Information Service, University of Utah, Salt Lake City, UT.
Disclaimer
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins